Gufic Biosciences438.00
+2.00 (+0.46%)

Gufic Biosciences Share Price

438.00+2.00 (+0.46%)
+18.39% past 1 Year

Corporate filings & documents

Announcements

Intimation of Credit Rating is attached herewith
1 week ago
Intimation of Credit Rating is attached herewith
1 week ago
Voting Results and Consolidated Scrutinizer Report of 42nd Annual General Meeting of the Company held on Friday September 04 2026 is attached herewith
1 week ago
Voting Results and Consolidated Scrutinizer Report of 42nd Annual General Meeting of the Company held on Friday September 04 2026 is attached herewith
1 week ago
Proceedings of the 42nd Annual General Meeting of the Company held on Friday September 04 2026 is attached herewith
2 weeks ago
Proceedings of the 42nd Annual General Meeting of the Company held on Friday September 04 2026 is attached herewith
2 weeks ago
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 - Promotion and Change in Designation of Senior Management Personnel is attached herewith
2 weeks ago
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 - Promotion and Change in Designation of Senior Management Personnel is attached herewith
2 weeks ago
Written Transcript of Earnings Conference Call held on August 17 2026 at 04:30 p.m. is attached herewith
1 month ago
Written Transcript of Earnings Conference Call held on August 17 2026 at 04:30 p.m. is attached herewith
1 month ago
Newspaper advertisement regarding Special Window for re-lodgement of transfer and dematerialization of physical shares is attached herewith
1 month ago
Newspaper advertisement regarding Special Window for re-lodgement of transfer and dematerialization of physical shares is attached herewith
1 month ago
Intimation of Audio Recording of Earnings Conference Call held on August 17 2026 at 04:30 p.m. is attached herewith
1 month ago
Intimation of Audio Recording of Earnings Conference Call held on August 17 2026 at 04:30 p.m. is attached herewith
1 month ago
Newspaper Advertisement of Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30 2026 is attached herewith.
1 month ago
Newspaper Advertisement of Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30 2026 is attached herewith.
1 month ago
Investor Presentation for the Quarter ended June 30 2026 is attached herewith
1 month ago
Investor Presentation for the Quarter ended June 30 2026 is attached herewith
1 month ago
Approval for Incorporation of Subsidiary in the Philippines and Investment by way of Subscription to its Equity Share Capital is attached herewith.
1 month ago
Approval for Incorporation of Subsidiary in the Philippines and Investment by way of Subscription to its Equity Share Capital is attached herewith.
1 month ago
Unaudited Financial Results (Standalone and Consolidated) for the Quarter ended June 30 2026 is attached herewith.
1 month ago
Unaudited Financial Results (Standalone and Consolidated) for the Quarter ended June 30 2026 is attached herewith.
1 month ago
Outcome of the Board of Directors Meeting held on Friday August 14 2026 is attached herewith.
1 month ago
Outcome of the Board of Directors Meeting held on Friday August 14 2026 is attached herewith.
1 month ago
Newspaper Advertisement - Notice of 42nd Annual General Meeting of the Company and evoting details is attached herewith.
1 month ago
Newspaper Advertisement - Notice of 42nd Annual General Meeting of the Company and evoting details is attached herewith.
1 month ago
Business Responsibility and Sustainability Report for the Financial Year ended March 31 2026 is attached herewith
1 month ago
Business Responsibility and Sustainability Report for the Financial Year ended March 31 2026 is attached herewith
1 month ago
Annual Report for the Financial Year 2025-2026 alongwith Notice of 42nd Annual General Meeting is attached herewith.
1 month ago
Annual Report for the Financial Year 2025-2026 alongwith Notice of 42nd Annual General Meeting is attached herewith.
1 month ago
Intimation for book closure and record date for the purpose of 42nd Annual General Meeting and payment of final dividend for the financial year ended March 31 2026
1 month ago
Intimation for book closure and record date for the purpose of 42nd Annual General Meeting and payment of final dividend for the financial year ended March 31 2026
1 month ago
Intimation of 42nd Annual General Meeting is attached herewith
1 month ago
Intimation of 42nd Annual General Meeting is attached herewith
1 month ago
Intimation of Earnings Conference Call scheduled to be held on August 17 2026 is attached herewith
1 month ago
Intimation of Earnings Conference Call scheduled to be held on August 17 2026 is attached herewith
1 month ago
Gufic Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30 2026
1 month ago
Gufic Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30 2026
1 month ago
Newspaper Advertisement - Notice of the 42nd Annual General Meeting of the Company is attached herewith
1 month ago
Newspaper Advertisement - Notice of the 42nd Annual General Meeting of the Company is attached herewith
1 month ago
Intimation for Re-appointment of Mr. Pankaj Jayakumar Gandhi (DIN: 00001858) as the Whole Time Director of the Company is attached herewith.
1 month ago
Intimation for Re-appointment of Mr. Pankaj Jayakumar Gandhi (DIN: 00001858) as the Whole Time Director of the Company is attached herewith.
1 month ago
Outcome of the Board of Directors Meeting held on Friday July 31 2026 is attached herewith
1 month ago
Outcome of the Board of Directors Meeting held on Friday July 31 2026 is attached herewith
1 month ago
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended June 30 2026 is attached herewith
2 months ago
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended June 30 2026 is attached herewith
2 months ago
Newspaper Advertisement regarding Notice for transfer of equity shares to Investor Education and Protection Fund (IEPF) Authority is attached herewith
2 months ago
Newspaper Advertisement regarding Notice for transfer of equity shares to Investor Education and Protection Fund (IEPF) Authority is attached herewith
2 months ago
Intimation of closure of Trading Window for the quarter ended June 30 2026 is attached herewith
2 months ago
Intimation of closure of Trading Window for the quarter ended June 30 2026 is attached herewith
2 months ago

Concalls & investor presentations

Aug 2026
ConcallPresentation
Aug 2026
Jun 2026
ConcallPresentation
May 2026
Feb 2026
ConcallPresentation
Feb 2026
Aug 2025
ConcallPresentation
Aug 2025
May 2025
Feb 2025
Nov 2024
Aug 2024
May 2024
ConcallPresentation
May 2024
Feb 2024
ConcallPresentation
Feb 2024
Nov 2023
ConcallPresentation
Nov 2023
Aug 2023
ConcallPresentation
Aug 2023
May 2023
ConcallPresentation
May 2023
Feb 2023
ConcallPresentation
Nov 2022
ConcallPresentation
Nov 2022
Aug 2022
ConcallPresentation
Aug 2022
May 2022
ConcallPresentation
May 2022
Feb 2022
ConcallPresentation
Nov 2021
ConcallPresentation
Aug 2021
ConcallPresentation
Jun 2021
ConcallPresentation
Jun 2021

Gufic Biosciences Ltd Share Price Today

The Gufic Biosciences Ltd share price today is ₹447.85. During the trading session, the Gufic Biosciences Ltd share price opened at ₹449.90 and recorded an intraday high of ₹467.80 and a low of ₹447.00. Last closing price was ₹444.90. Over the past 52 weeks, the Gufic Biosciences Ltd share price has ranged between ₹268.00 and ₹467.80. The current Gufic Biosciences Ltd stock price reflects real-time market activity based on executed trades on the exchange.